FDA Inspection 1170427 — Mylan Laboratories Limited

Mylan Laboratories Limited — FEI 3007512701

The FDA completed an inspection of Mylan Laboratories Limited on May 27, 2022 in Anekal Taluk, Bangalore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 27, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Anekal Taluk, Bangalore (India)

Citations

IDCFRDescription
360321 CFR 211.160(b)Scientifically sound laboratory controls
360921 CFR 211.160(b)(2)In-process sample representation/identification